DIN 02456796 — NINLARO 2.3 MG
NINLARO is a capsule of Ixazomib marketed by TAKEDA CANADA INC. The full Ixazomib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02456796
- Brand name
- NINLARO
- Active ingredient
- Ixazomib
- Strength
- 2.3 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Proteasome inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ixazomib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02456818 | NINLARO | 3 MG | CAPSULE | TAKEDA CANADA INC | MARKETED |
| 02456826 | NINLARO | 4 MG | CAPSULE | TAKEDA CANADA INC | MARKETED |